Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam B Zeisel

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2023
miR-21p-5p coordinates biological pathways to promote MASLD progressionPatricia Aspichueta, Mirjam B Zeisel
Soins; La Revue De Reference Infirmiere|January 14, 2014
[Research on hepatitis c and therapeutic options]Mirjam B Zeisel, Thomas F Baumert
Expert Review of Clinical Pharmacology|June 28, 2016
Hepatitis B virus: is a cure possible?Mirjam B Zeisel, Thomas F Baumert
Future Microbiology|June 5, 2009
HCV entry and neutralizing antibodies: lessons from viral variantsMirjam B Zeisel, Thomas F Baumert
Journal of Hepatology|December 20, 2005
Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied researchMirjam B Zeisel, Thomas F Baumert
Hepatology (Baltimore, Md.)|May 27, 2016
Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinomaMirjam B Zeisel, Thomas F Baumert
Lancet (London, England)|January 15, 2017
Clinical development of hepatitis C virus host-targeting agentsMirjam B Zeisel, Thomas F Baumert
Journal of Clinical Medicine|April 30, 2021
Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular CarcinomaMirjam B Zeisel, Francesca Guerrieri, Massimo Levrero
Hepatology (Baltimore, Md.)|May 5, 2017
Toward novel immunocompetent animal models for hepatitis B virus infectionLaurent Mailly, Mirjam B Zeisel, Thomas F Baumert
Medecine Sciences : M/S|December 18, 2015
[Locked outside: cure of chronic hepatitis C using an entry inhibitor]Laurent Mailly, Mirjam B Zeisel, Thomas F Baumert
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2023
miR-21p-5p coordinates biological pathways to promote MASLD progressionPatricia Aspichueta, Mirjam B Zeisel
Soins; La Revue De Reference Infirmiere|January 14, 2014
[Research on hepatitis c and therapeutic options]Mirjam B Zeisel, Thomas F Baumert
Expert Review of Clinical Pharmacology|June 28, 2016
Hepatitis B virus: is a cure possible?Mirjam B Zeisel, Thomas F Baumert
Future Microbiology|June 5, 2009
HCV entry and neutralizing antibodies: lessons from viral variantsMirjam B Zeisel, Thomas F Baumert
Journal of Hepatology|December 20, 2005
Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied researchMirjam B Zeisel, Thomas F Baumert
Hepatology (Baltimore, Md.)|May 27, 2016
Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinomaMirjam B Zeisel, Thomas F Baumert
Lancet (London, England)|January 15, 2017
Clinical development of hepatitis C virus host-targeting agentsMirjam B Zeisel, Thomas F Baumert
Journal of Clinical Medicine|April 30, 2021
Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular CarcinomaMirjam B Zeisel, Francesca Guerrieri, Massimo Levrero
Hepatology (Baltimore, Md.)|May 5, 2017
Toward novel immunocompetent animal models for hepatitis B virus infectionLaurent Mailly, Mirjam B Zeisel, Thomas F Baumert
Medecine Sciences : M/S|December 18, 2015
[Locked outside: cure of chronic hepatitis C using an entry inhibitor]Laurent Mailly, Mirjam B Zeisel, Thomas F Baumert
Pageof 11